ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NXTC NextCure Inc

1.45
0.08 (5.84%)
After Hours
Last Updated: 08:09:21
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NextCure Inc NXTC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.08 5.84% 1.45 08:09:21
Open Price Low Price High Price Close Price Previous Close
1.40 1.39 1.58 1.49 1.37
more quote information »

Recent News

Date Time Source Heading
03/5/202406:05GLOBENextCure Provides Business Update and Reports First Quarter..
25/4/202406:05GLOBENextCure to Present Phase 1b Data of NC410 in Combination..
08/4/202421:00GLOBENextCure and LCB Present Preclinical Data on B7-H4 Antibody..
04/4/202422:05GLOBENextCure Appoints Dr. Rakesh Dixit to Scientific Advisory..
02/4/202422:00GLOBENextCure to Present at 23rd Annual Needham Virtual..
21/3/202423:55GLOBENextCure Provides Business Update and Reports Full Year 2023..
06/3/202400:05GLOBENextCure Publishes Preclinical Data Demonstrating Function..
02/2/202408:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202408:05GLOBENextCure Presents Preclinical Data on a Novel Therapeutic..
21/12/202323:05GLOBENextCure Publishes Non-Clinical Data Demonstrating..
14/12/202323:15EDGAR2Form 8-K - Current report
14/12/202322:45GLOBENextCure Provides Year-End Clinical Pipeline Updates
20/11/202323:00GLOBENextCure to Present at the 35th Annual Piper Sandler..
16/11/202308:05GLOBENextCure Publishes Non-Clinical Data Defining the Mechanism..
03/11/202307:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:10EDGAR2Form 8-K - Current report
03/11/202307:05GLOBENextCure Provides Business Update and Reports Third Quarter..
17/10/202323:05GLOBEPreclinical Data Demonstrate Anti-Siglec-15 Treatment..
27/9/202306:05GLOBENextCure Presents Preclinical Data on NC181, a Novel..
12/9/202322:05GLOBEA Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in..
08/9/202306:05GLOBENextCure and Nordic Bioscience Publish Review Article on the..
06/9/202306:05GLOBEPreclinical Data Demonstrate Potential Application of..
31/8/202321:00GLOBENextCure to Present at the H.C. Wainwright 25th Annual..
05/8/202306:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/8/202306:30EDGAR2Form S-3 - Registration statement under Securities Act of..
04/8/202306:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:16EDGAR2Form 8-K - Current report
04/8/202306:05GLOBENextCure Provides Business Update and Reports Second Quarter..
20/7/202306:05EDGAR2Form 8-K - Current report
22/6/202306:05GLOBENextCure Presents Non-Clinical Data Defining the Mechanism..
09/5/202321:00GLOBENextCure to Present at the JMP Securities Life Sciences..
05/5/202306:05GLOBENextCure Provides Business Update and Reports First Quarter..

Your Recent History

Delayed Upgrade Clock